Here is how I see it: the reported neoplasms (abnormal growths) in 3% of the patients in the stud is enough and of the 23 neoplasms with the 9 tested malignant in the treatment group and 2 in the placebo group is significant enough to potentially warrant it mute.
These statistics weigh against ANP today.
I will argue that the trading halt will be backed by an announcement trying to stop the rot.
Will be interesting to see what ANP has to say.
is the game over?
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
